Open access
Oct 2026
Alzheimer’s disease risk gene Wwox controls amyloid pathology through metabolic reprogramming
Findings identify WWOX as a regulator of neuronal metabolic state, linking genetic risk to amyloid pathology via metabolic reprogramming, and highlight WWOX activation as a potential therapeutic strategy in Alzheimer’s disease.
Hannah J. Lucas-Clarke, D. Maddison, L. Amadio et al.
· Brain Communications · 0 citations